Skip to content

Study Details

Testing the drug XEN1101 in adults with epilepsy

(IRB#: IRB_00164793)

This study will test a new study drug called XEN1101 to help patients with epilepsy. Epilepsy is a disease that may occur due to a genetic disorder or brain injury. This condition affects the nerves in the brain causing seizures. The study wants to see if XEN110 will help people with the disease and is safe. People in this study will all receive XEN1101 once a day. The drug is taken as a swallowed pill. Being in the study requires regular clinic visits for about 8 months during participation. Medical tests will be done during the study to track the health of participants.


  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18 to 75 years old
  • Successfully completed Study X-TOLE2, X-TOLE3, or X-ACKT
  • Willing to use specific birth control
  • Able to attend in person at the University of Utah

Exclusion Criteria

  • Pregnant, breastfeeding, or planning to become pregnant prior to 6 months after the last dose of study drug
  • Planning to enter a study with a different study drug or device for the treatment of epilepsy
  • Any other medical condition during the study and until 28 days after completing the study

Will I be paid for my time?


For more information contact:

Marissa Castillo


IRB#: IRB_00164793

PI: Amir Arain

Department: NEUROLOGY

Approval Date: 2023-08-23 06:00:00

Study Categories: Brain Health Studies

Specialties: Neurology

Last Updated: 6/8/23